Verve Therapeutics (VERV) Stock Chart & Stock Price History → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free VERV Stock Alerts $6.23 0.00 (0.00%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Verve Therapeutics Stock Price Performance5 Day Performance+3.66%1 Month Performance-14.77%3 Month Performance-53.09%6 Month Performance-45.78%Year-To-Date Performance-55.31%1 Year Performance-64.72% Receive VERV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 VERV Stock Chart for Wednesday, May, 15, 2024 VERV Chart by TradingView Verve Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/15/2024$6.23$6.23$6.62$6.121.22 million shs$523.07 million05/14/2024$6.22$6.23+0.16%$6.83$6.131.49 million shs$523.07 million05/13/2024$6.01$6.22+3.49%$6.83$6.101.71 million shs$522.23 million05/10/2024$6.36$6.01-5.50%$6.43$5.881.60 million shs$504.36 million05/09/2024$6.08$6.36+4.61%$6.73$6.131.96 million shs$533.73 million05/08/2024$6.16$6.08-1.30%$6.29$5.991.46 million shs$510.23 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2024$6.41$6.16-3.90%$6.46$6.05886,791 shs$516.95 million05/06/2024$6.41$6.41$6.73$6.28811,985 shs$537.95 million05/03/2024$6.15$6.41+4.23%$7.00$6.281.39 million shs$537.93 million05/02/2024$6.00$6.15+2.50%$6.25$6.00949,350 shs$516.11 million05/01/2024$6.01$6.00-0.17%$6.56$5.841.76 million shs$504.38 million04/30/2024$6.26$6.01-3.99%$6.31$5.961.02 million shs$502.56 million04/29/2024$6.16$6.26+1.62%$6.54$6.11933,090 shs$523.46 million04/26/2024$6.22$6.16-0.96%$6.41$6.02791,349 shs$515.10 million04/25/2024$6.58$6.22-5.47%$6.35$6.051.22 million shs$520.12 million04/24/2024$6.88$6.58-4.36%$6.92$6.531.00 million shs$550.22 million04/23/2024$6.91$6.88-0.43%$7.41$6.81962,924 shs$575.31 million04/22/2024$6.64$6.91+4.07%$7.03$6.46909,064 shs$577.81 million04/19/2024$6.66$6.64-0.30%$6.80$6.421.10 million shs$555.24 million04/18/2024$6.74$6.66-1.19%$6.85$6.531.25 million shs$556.91 million04/17/2024$7.14$6.74-5.60%$7.27$6.721.15 million shs$563.60 million04/16/2024$7.31$7.14-2.33%$7.26$7.04691,035 shs$597.05 million04/15/2024$7.60$7.31-3.82%$7.73$7.131.37 million shs$611.26 million04/12/2024$8.07$7.60-5.82%$8.02$7.541.19 million shs$635.51 million04/11/2024$8.01$8.07+0.75%$8.40$7.901.08 million shs$674.81 million04/10/2024$8.75$8.01-8.46%$8.32$7.761.72 million shs$669.80 million04/09/2024$8.40$8.75+4.17%$8.77$8.37872,383 shs$731.68 million04/08/2024$8.52$8.40-1.41%$8.75$8.241.03 million shs$702.40 million04/05/2024$8.68$8.52-1.84%$8.75$8.181.38 million shs$712.44 million04/04/2024$8.71$8.68-0.34%$9.23$8.641.63 million shs$725.81 million04/03/2024$8.32$8.71+4.69%$8.92$8.172.73 million shs$728.33 million04/02/2024$12.79$8.32-34.95%$9.28$7.3610.02 million shs$695.72 million04/01/2024$13.28$12.79-3.69%$13.24$12.52868,948 shs$1.07 billion03/29/2024$13.28$13.28$13.63$12.94647,690 shs$1.11 billion03/28/2024$13.19$13.28+0.68%$13.63$12.96647,590 shs$1.11 billion03/27/2024$12.79$13.19+3.13%$13.24$12.65633,369 shs$1.10 billion03/26/2024$13.16$12.79-2.81%$13.43$12.77663,883 shs$1.07 billion03/25/2024$12.97$13.16+1.46%$13.23$12.81524,538 shs$1.10 billion03/22/2024$13.21$12.97-1.82%$13.24$12.80584,615 shs$1.08 billion03/21/2024$13.38$13.21-1.27%$14.26$13.05888,884 shs$1.10 billion[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond03/20/2024$13.01$13.38+2.84%$13.54$12.67780,762 shs$1.12 billion03/19/2024$13.31$13.01-2.25%$13.48$12.89870,559 shs$1.09 billion03/18/2024$13.81$13.31-3.62%$13.81$12.82878,195 shs$1.11 billion03/15/2024$13.60$13.81+1.54%$14.03$13.474.71 million shs$1.15 billion03/14/2024$14.34$13.60-5.16%$14.30$13.39971,086 shs$1.14 billion03/13/2024$13.92$14.34+3.02%$14.51$13.85950,441 shs$1.20 billion03/12/2024$14.42$13.92-3.47%$14.57$13.601.07 million shs$1.16 billion03/11/2024$14.96$14.42-3.61%$15.55$14.23877,426 shs$1.21 billion03/08/2024$14.94$14.96+0.13%$16.03$14.72644,869 shs$1.25 billion03/07/2024$15.07$14.94-0.86%$15.81$14.91937,113 shs$952.43 million03/06/2024$15.14$15.07-0.46%$15.62$14.921.19 million shs$960.71 million03/05/2024$15.84$15.14-4.42%$16.05$14.841.11 million shs$965.22 million03/04/2024$16.29$15.84-2.76%$16.43$15.371.31 million shs$1.01 billion03/01/2024$17.05$16.29-4.46%$17.33$16.151.81 million shs$1.04 billion02/29/2024$17.96$17.05-5.07%$19.34$16.891.88 million shs$1.09 billion02/28/2024$17.54$17.96+2.39%$18.96$16.552.15 million shs$1.14 billion02/27/2024$14.44$17.54+21.47%$17.73$15.002.40 million shs$1.12 billion02/26/2024$13.45$14.44+7.36%$14.53$13.231.29 million shs$920.55 million02/23/2024$13.32$13.45+0.98%$13.56$13.20547,273 shs$857.44 million02/22/2024$13.13$13.32+1.45%$13.77$13.12807,467 shs$849.15 million02/21/2024$13.06$13.13+0.54%$13.21$12.65538,057 shs$837.04 million02/20/2024$13.09$13.06-0.23%$13.47$12.87704,475 shs$832.58 million02/19/2024$13.09$13.09$13.32$12.64690,800 shs$834.53 million02/16/2024$13.28$13.09-1.43%$13.32$12.64690,685 shs$834.49 million02/15/2024$12.75$13.28+4.16%$13.55$12.81922,301 shs$846.64 million02/14/2024$12.19$12.75+4.59%$12.83$12.041.14 million shs$812.81 million Related Companies: Altimmune Stock Chart Larimar Therapeutics Stock Chart KalVista Pharmaceuticals Stock Chart Travere Therapeutics Stock Chart Oculis Stock Chart Shattuck Labs Stock Chart COMPASS Pathways Stock Chart Adlai Nortye Stock Chart Arbutus Biopharma Stock Chart Astria Therapeutics Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersDems have chosen Biden replacement?Paradigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityAmerica’s worst nightmare?Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.